Sorcero is an AI and data intelligence platform built for life sciences that unifies scattered structured and unstructured medical content into a single source teams can query.
Medical affairs, safety, and scientific communications teams at large pharmaceutical companies use its medically tuned AI to surface evidence, capture insights, and shape scientific and market strategy. The platform reads across publications, congress sessions, safety cases, and medical inquiries.
Medical and regulatory language is precise in ways general models are not, and in this industry traceability is not optional. Tuning the AI to that language is what lets a medical affairs team put its name on the answer.
NZVC invested in Sorcero from NZVC Fund I. We file the company under AI and B2B SaaS on the portfolio wall.
We backed Sorcero because medical affairs sits on top of an unmanageable volume of scientific evidence and has had few good tools to make sense of it. The team built AI tuned specifically for medical and regulatory language, which matters enormously in an industry where accuracy and traceability are not optional. Working with a meaningful share of the largest global pharma companies gave us confidence that the product earns trust in a demanding, high-stakes market.